ALOX15 oxidises 17(S)-Hp-DHA to PDX

Stable Identifier
R-HSA-9024872
Type
Reaction [transition]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

15-lipoxygenase (ALOX15) can mediate a second lipoxygenation reaction where 17(S)-Hp-DHA is oxidised to the production of the protectin D1 (PD1) isomer PDX (Hong et al. 2003, Serhan et al. 2006, Chen et al. 2009). The chemical structure of PDX is 10(S),17(S)-dihydroxy-docosahexa-4Z,7Z,11E,13Z,15E,19Z-enoic acid. It differs from PD1, having E,Z,E geometry (PDX) instead of E,E,Z (PD1) and S configuration at carbon 10 instead of R (Chen et al. 2009). PDX is not a major product of leukocytes and has low potency compared to PD1 as a regulator of polymorphonuclear leukocyte (PMN) infiltration (Serhan et al. 2006).

Literature References
PubMed ID Title Journal Year
12590139 Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation

Hong, S, Gronert, K, Devchand, PR, Moussignac, RL, Serhan, CN

J. Biol. Chem. 2003
16424216 Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes

Serhan, CN, Gotlinger, K, Hong, S, Lu, Y, Siegelman, J, Baer, T, Yang, R, Colgan, SP, Petasis, NA

J. Immunol. 2006
19818771 Full characterization of PDX, a neuroprotectin/protectin D1 isomer, which inhibits blood platelet aggregation

Chen, P, Fenet, B, Michaud, S, Tomczyk, N, VĂ©ricel, E, Lagarde, M, Guichardant, M

FEBS Lett. 2009
Participants
Participant Of
Catalyst Activity
Catalyst Activity
Title
arachidonate 15-lipoxygenase activity of ALOX15 [cytosol]
Physical Entity
Activity
Orthologous Events
Authored
Reviewed
Created
Cite Us!